Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Immune Cell-trophoblast-interaction in Pregnancy Disorders

NCT03313024 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT03313024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03313024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Immune Cell-trophoblast-interaction in Pregnancy Disorders
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Recruiting
Start date
September 26, 2017
Completion date
October 31, 2027
Enrollment
1,580 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus in pregnancy, preeclampsia, pregnancy complications